Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Benicar

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Benicar was produced by Daiichi Sankyo.

Daiichi Sankyo to shut down German antibody unit U3

Daiichi Sankyo to shut down German antibody unit U3

The restricting comes as Daiichi Sankyo faces the loss of patent protection in the US for Benicar (olmesartan), a $2.4bn-a-year product used to treat high blood pressure.  .

Daiichi Sankyo cuts a swathe through US workforce

Daiichi Sankyo cuts a swathe through US workforce $2.4bn-a-year high blood pressure drug Benicar (olmesartan) is due to succumb to generic competition in the coming months and it is not uncommon for a big brand to ... The company will need late-stage pipeline candidates to deliver if it is to ride out

Daiichi Sankyo pays $39m in whistleblower case

Daiichi Sankyo pays $39m in whistleblower case several of its products, including high blood pressure treatment Benicar (olmesartan) and various combinations of the drug with other antihypertensive agents.

FDA approves Takeda antihypertensive

Daiichi Sankyo's Benicar (olemesartan).

Takeda files combination blood pressure drug

In other studies, the combination was compared to azilsartan medoxomil co-administered with the generic diuretic hydrochlorothiazide and with a fixed-dose combination of Daiichi Sankyo's Benicar (olmesartan) and hydrochlorothiazide. ... Phase III

1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...